glucagon diabetes peptides online manufacturer Manufacturer

Glucagon (human),CAS#: 16941-32-5, Molecular Weight:3482.8 A 29 amino acid sequence containing peptide hormone processed from proglucagon that keeps glucose homeostasis in vivo in both animals and humans. It is also believed to be a potential tool in the therapeutic treatment of diabetes. Technical Data for Glucagon (Human, Porcine) M. Wt 3482.78 Formula C153H225N43O49S Sequence HSQGTFTSDYSKYLDSRRAQDFVQWLMNT Storage Store at -20C Purity 95% (HPLC) CAS Number 16941-32-5

GLP-2 (1-34) (human),CAS#: 99120-49-7, Catalog Number: KS032009 Glucagon-like peptide-2 (GLP-2) promotes nutrient absorption via expansion of the mucosal epithelium by stimulation of crypt cell proliferation and inhibition of apoptosis in the small intestine. It also reduces epithelial permeability, and decreases meal-stimulated gastric acid secretion and gastrointestinal motility. GLP-2 promotes the expansion of the intestinal epithelium through stimulation of the GLP-2

Exendin-4; Exenatide,CAS#: 141758-74-9, Catalog Number: KS031004 Exendin-4 (Exenatide), originally isolated from Heloderma suspectum venom, stimulates acinar cAMP without causing amylase release, binds with similar affinity to the glucagon-like peptide 1 receptor, and is used in the treatment of type 2 diabetes. Technical Data for Exendin-4 M. Wt 4186.61 Formula C184H282N50O60S Sequence (Modifications: Ser-39 = C-terminal amide) Storage Store at -20C Purity 95% (HPLC) CAS

Exendin-4 (9-39) CAS 133514-43-9 Catalog Number KS031013 This truncated Exendin-4 peptide, Exendin (9-39) amide, is a potent Glucagon-Like Peptide 1 (GLP-1) receptor antagonist. Unlike the full length Exendin-4 (a GLP-1 agonist), Exendin (9-39) antagonizes GLP-1stimulated insulin release after food intake. It is a competitive inhibitor of Exendin-3 and Exendin-4. Technical Data for Exendin-3 (9-39) amideM. Wt3369.79FormulaC149H234N40O47SSequence(Modifications: Ser-31 = C

GLP-2 (1-33) (human),CAS#: 223460-79-5, Catalog Number: KS032008 This is a fragment of human intestinal growth factor glucagon-like peptide 2, GLP2, containing amino acids 146 to 178. It is an intestinotrophic growth hormone that promotes many aspects of intestinal function, including enhancement of mucosal growth and promotion of nutrient absorption. GLP-2 is a hormone that can rapidly improve intestinal epithelial barrier function. Technical Data for GLP-2 (human) M. Wt

Amylin (rat),CAS#: 124447-81-0, Catalog Number: KS032012 Rat/mouse Amylin differs from the human version in 6 amino acids: H18R, F23L, A25P, I26V, S28P and S29P (first letter is the amino acid of the human sequence). Unlike the human IAPP (Amylin), rat Amylin does not form amyloid fibers. Technical Data for Amylin (rat) M. Wt 3920.43 Formula C167H272N52O53S2 Sequence (Modifications: Tyr-37 = C-terminal amide, Disulfide bridge between 2 - 7) Storage Store at -20C CAS Number

Sermaglutide CAS 910463-68-2 Molecular Weight 4113.64 On September 20, 2019, the FDA officially approved the marketing application for Sommarutide, which is used in combination with diet and exercise to improve blood sugar control in patients with type 2 diabetes. Sommarutide is a human GLP-1 analogue with high albumin affinity and a long half-life. It can be administered once a week to stimulate insulin secretion and inhibit glucagon secretion in a glucose-dependent manner.

A 29 amino acid sequence containing peptide hormone processed from proglucagon that keeps glucose homeostasis in vivo in both animals and humans. It is also believed to be a potential tool in the therapeutic treatment of diabetes.

A 29 amino acid sequence containing peptide hormone processed from proglucagon that keeps glucose homeostasis in vivo in both animals and humans. It is also believed to be a potential tool in the therapeutic treatment of diabetes.